NASDAQ
17.70USD
-0.92 (-4.94%)
We have scored 8 news catalysts on Fortrea Holdings Inc. (FTRE) over the past 12 months. The biggest single-day move next to one of them came Nov 2, 2025, when FTRE closed +4.3%: “Focus Partners Advisor Solutions LLC Makes New $78,000 Investment in Fortrea Holdings Inc. $FTRE”. Coverage across the window leans positive (average ticker sentiment +0.19). Most of the impact sits in earnings revision trend and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Suppliers, customers, partners and competitors of Fortrea Holdings Inc., taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for FTRE: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Market cap
1.7B
P/E
—
EPS
—
Beta
1.95
52W range
8.305-21.39
Day range
17.64–18.45
Open
18.25
Prev close
18.62
Volume
762.1K
Avg volume
1.5M
Dividend
0.00
IPO
2023-06-20
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Fortrea Holdings Inc. — not a sector bucket. Click an edge to see the articles that established the link.
